Ventracor

Ventracor is a leading provider of cardiac assist systems, dedicated to the research, development, manufacture, and commercialization of advanced medical technologies. Ventracor's core product is the VentrAssist LVAD (Left Ventricular Assist Device), an implantable blood pump created as a crucial alternative to heart transplants for patients experiencing heart failure. With a commitment to improving patient outcomes and advancing cardiac care, Ventracor strives to deliver innovative solutions to healthcare providers globally.

Ventracor operates across key regions, including Australia, the United States, and Europe, ensuring widespread access to its life-saving technologies. Ventracor's dedication to quality and innovation has established it as a trusted partner in the medical community. The VentrAssist LVAD has been implanted in over 400 patients worldwide, demonstrating its impact and effectiveness.

Ventracor is headquartered in Chatswood, Sydney, Australia. As Ventracor continues to expand its reach and enhance its product offerings, more detailed company information will be completed soon with the support of the company’s management. We invite the manager of Ventracor to create a customized and exclusive company showcase and product listing on our platform to further highlight their contributions to the medical field.